A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer.
Yang ZhangZi-Xian WangLin ShenJin LiJing HuangWei-Guo SuDong-Sheng ZhangRui-Hua XuPublished in: Cancer communications (London, England) (2022)